Polycythemia vera: Updated Onkopedia Guidelines recommend Interferon alfa as preferred First-line Treatment

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Interferon alfa: Effects of long-term treatment for polycythemia vera
    Silver, RT
    SEMINARS IN HEMATOLOGY, 1997, 34 (01) : 40 - 50
  • [2] Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate
    Silver R.T.
    Current Hematologic Malignancy Reports, 2007, 2 (1) : 43 - 46
  • [3] BESREMi® New First-line Monotherapy for the Treatment of Polycythemia vera without symptomatic Splenomegaly in Adults
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2020, 47 (01) : 100 - 100
  • [4] Long term effects of the treatment of polycythemia vera (PV) with recombinant interferon alfa (rIFNα).
    Silver, RT
    Pahuja, M
    Klein, J
    BLOOD, 2000, 96 (11) : 741A - 741A
  • [5] Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Settings
    Yacoub, Abdulraheem
    Mascarenhas, John
    Mesa, Ruben A.
    Kosiorek, Heidi E.
    Rampal, Raajit K.
    Silver, Richard T.
    Salama, Mohamed E.
    Siwoski, Olivia
    Dueck, Amylou C.
    Sandy, Lonette
    McMullin, Mary Frances
    Ewing, Joanne
    O'Connell, Casey L.
    Mead, Adam J.
    De Stefano, Valerio
    Weinberg, Rona Singer
    Baer, Maria R.
    Kessler, Craig M.
    Winton, Elliott F.
    Vannucchi, Alessandro M.
    Kremyanskaya, Marina
    Vadakara, Joseph
    Rosti, Vittorio
    Hexner, Elizabeth O.
    Rondelli, Damiano
    Arcasoy, Murat O.
    Rambaldi, Alessandro
    Ritchie, Ellen K.
    Barbui, Tiziano
    Kiladjian, Jean-Jacques
    Harrison, Claire N.
    Prchal, Josef T.
    Hoffman, Ronald
    BLOOD, 2019, 134
  • [6] New international guidelines recommend angiotensin II receptor blockers as first-line hypertension treatment
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1999, 89 : C179 - C179
  • [7] Is it time to make interferon-alfa first-line therapy?
    Kiladjian, J. J.
    LEUKEMIA RESEARCH, 2016, 44 : S9 - S10
  • [8] Interferon alfa (rIFN alpha): Effects of long-term treatment for polycythemia vera (PV)
    Silver, RT
    BLOOD, 1995, 86 (10) : 188 - 188
  • [9] Interferon-alfa2 Treatment of Patients with Polycythemia Vera and Related Neoplasms Influences Deregulated Inflammation and Immune Genes in Polycythemia Vera and Allied Neoplasms
    Skov, Vibe
    Riley, Caroline
    Thomassen, Mads
    Kjaer, Lasse
    Larsen, Thomas Stauffer
    Bjerrum, Ole Weis
    Kruse, Torben A.
    Hasselbalch, Hans Carl
    BLOOD, 2018, 132
  • [10] BESREMi® New First-Line Monotherapy to Treat Polycythemia vera without symptomatic Splenomegaly in Adults
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 704 - 704
12345